Fernández-Dueñas, V.; Gómez-Soler, M.; Valle-León, M.; Watanabe, M.; Ferrer, I.; Ciruela, F.
Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. Int. J. Mol. Sci. 2019, 20, 3600.
https://doi.org/10.3390/ijms20143600
AMA Style
Fernández-Dueñas V, Gómez-Soler M, Valle-León M, Watanabe M, Ferrer I, Ciruela F.
Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. International Journal of Molecular Sciences. 2019; 20(14):3600.
https://doi.org/10.3390/ijms20143600
Chicago/Turabian Style
Fernández-Dueñas, VĂctor, Maricel GĂłmez-Soler, Marta Valle-LeĂłn, Masahiko Watanabe, Isidre Ferrer, and Francisco Ciruela.
2019. "Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay" International Journal of Molecular Sciences 20, no. 14: 3600.
https://doi.org/10.3390/ijms20143600
APA Style
Fernández-Dueñas, V., Gómez-Soler, M., Valle-León, M., Watanabe, M., Ferrer, I., & Ciruela, F.
(2019). Revealing Adenosine A2A-Dopamine D2 Receptor Heteromers in Parkinson’s Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. International Journal of Molecular Sciences, 20(14), 3600.
https://doi.org/10.3390/ijms20143600